Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
HS
Solana Company Class A Common Stock (DE)
HSDT
Mkt Cap
$145.8M
Volume
430.33K
Next Earnings
November 17th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
HS
HSDT
HS
Solana Company Class A Common Stock (DE)
HSDT
News
·
Solana Company (HSDT) Now Trades Above Golden Cross: Time to Buy?
Mkt Cap
$153.0M
Volume
430.33K
Next Earnings
November 17th
Chart
Financials
Earnings
News
About
Insider
Filings
Solana Company (HSDT) Now Trades Above Golden Cross: Time to Buy?
Solana Company (HSDT) has formed a bullish 'golden cross' technical pattern, with its 50-day moving average crossing above its 200-day moving average. The stock has rallied 11.5% over the past four weeks and holds a #3 (Hold) Zacks Rank. With no earnings estimate cuts and positive earnings revisions, the company appears positioned for potential near-term gains.
Zacks Investment Research · Oct 2, 2026
Solana Company (NASDAQ: HSDT) Announces Pricing of $15 Million Registered Direct Offering with a Global Institutional Investor
Solana Company (NASDAQ: HSDT) announced a $15 million registered direct offering, selling 4,369,356 shares of Class A common stock at $3.433 per share with accompanying warrants at $3.776 per share to a single institutional investor. The company plans to use proceeds for treasury growth, stock buybacks, and acquiring additional Solana tokens. The offering is expected to close on October 1, 2026.
GlobeNewswire Inc. · Sep 30, 2026
Forward Industries, Inc (“Forward”) - Rule 2.12 Announcement
Forward Industries, Inc. (NASDAQ: FWDI) has made a non-binding proposal to acquire Solana Company. As of July 1, 2026, Forward had 73.8 million outstanding common shares, along with options, RSUs, and warrants for additional shares. The announcement includes disclosure requirements under Irish Takeover Rules.
GlobeNewswire Inc. · Jul 1, 2026
UPDATED: Forward Industries Announces Letter of Intent to Acquire Solana Company (HSDT)
Forward Industries (NASDAQ: FWDI) announced a non-binding all-stock acquisition proposal to Solana Company (HSDT) on June 15, 2026, offering 0.386 FWDI shares per HSDT share (approximately 10% premium). HSDT's board declined the offer on June 12th without discussion. Forward believes a combined entity would better serve shareholders and the Solana ecosystem.
GlobeNewswire Inc. · Jun 16, 2026
Helius Announces FDA 510(k) Submission for PoNS® Device Label Expansion in Stroke
Helius Medical Technologies filed a 510(k) submission to the FDA seeking expanded indication for its PoNS device to treat gait and balance deficits in chronic stroke patients, based on clinical trials demonstrating statistically significant improvements in functional gait assessment.
GlobeNewswire Inc. · Sep 25, 2025
Helius Medical Technologies Announces Pricing of $9.1 Million Public Offering
Helius Medical Technologies, Inc. announced the pricing of its public offering of 2,768,600 shares of Class A common stock and warrants to purchase up to 2,768,600 shares of common stock at a combined public offering price of $3.27 per share and accompanying warrants. The offering is expected to raise gross proceeds of $9.1 million.
GlobeNewswire Inc. · Jun 5, 2025
Helius Medical Technologies, Inc. Announces Strong Enrollment of its Stroke Pivotal Study Exceeding Initial Target
Helius Medical Technologies has exceeded its initial enrollment target for its stroke registrational program, with 128 participants enrolled as of December 31, 2024. The company expects to reach the maximum enrollment of 150 participants by the end of January 2025 and is on track to submit for FDA authorization for the PoNS device in the stroke indication in the second quarter of 2025.
GlobeNewswire Inc. · Jan 21, 2025
Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference
Helius Medical Technologies, a neurotech company, announced its plans to participate in The ThinkEquity Conference on October 30, 2024, where management will present and hold one-on-one investor meetings.
GlobeNewswire Inc. · Oct 18, 2024
Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimulator (PoNS®) Controller and Mouthpiece
Helius Medical Technologies announced updates on reimbursement determinations from CMS for its PoNS device. CMS set the reimbursement rate for the PoNS Mouthpiece at $2,963.30, which Helius plans to challenge. CMS deferred the final determination for the PoNS Controller to the next cycle.
GlobeNewswire Inc. · Oct 14, 2024
Helius Medical Technologies, Inc. Completes Site Participation Enrollment for its U.S. Registrational Program in Stroke
-- Inclusion of the top neurorehabilitation centers REHABOLOGYM, Neurology Center of New England, and MGH Institute of Health Professions completes site participation enrollment for the U.S. registrational program in stroke -- -- In Canada, an additional study on the use of Portable Neuromodulation Stimulator (PoNS®) Therapy to treat stroke has started to support Canadian reimbursement and U.S. approval for stroke --
GlobeNewswire Inc. · Jun 17, 2024
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
HS
HSDT
Solana Company Class A Common Stock (DE)
Buy
Sell
Market
Limit
Soon
HSDT
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any HSDT yet.
Related Tickers
Earnings